In Brief: Zila Pharmaceuticals
This article was originally published in The Tan Sheet
Zila Pharmaceuticals: Zilactin medicated gel for mouthsores is launching in Korea and Japan by the end of the summer, to be followed by the rest of the Far East, the firm predicts. Zila is currently in negotiations for distribution of Zilactin in Latin America, Europe and the Middle East...
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC